Top Cited Papers
Open Access
Abstract
Diseases of infection, of neurodegeneration (such as Alzheimer's and Parkinson's diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done. These approaches depend on the prior identification of clinically and biologically validated targets. This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.
Funding Information
  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (172033)
  • European Cooperation in Science and Technology (CM15135)
  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (172033)

This publication has 107 references indexed in Scilit: